Log in
Enquire now
‌

US Patent 10533016 Compounds that participate in cooperative binding and uses thereof

Patent 10533016 was granted and assigned to Revolution Medicines, Inc. on January, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Revolution Medicines, Inc.
0
Current Assignee
‌
Revolution Medicines, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105330160
Patent Inventor Names
Brian Roger Bowman0
Dylan Talbot Stiles0
Gregory Lawrence Verdine0
Mathew Edward Sowa0
Sharon Ann Townson0
Uddhav Kumar Shigdel0
Jay Paul Morgenstern0
Joshua Alan Van Dyke Blodgett0
...
Date of Patent
January 14, 2020
0
Patent Application Number
155423500
Date Filed
January 8, 2016
0
Patent Citations
‌
US Patent 10203323 Identifying new therapeutic agents
Patent Citations Received
‌
US Patent 11987590 Compounds that participate in cooperative binding and uses thereof
0
‌
US Patent 11555054 Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
‌
US Patent 11566007 Ras inhibitors
‌
US Patent 11066416 Rapafucin derivative compounds and methods of use thereof
‌
US Patent 11608346 Ras inhibitors
‌
US Patent 11644460 Identifying new therapeutic agents
0
‌
US Patent 11690915 Ras inhibitors
0
‌
US Patent 11708391 Rapaglutins, novel inhibitors of GLUT and use thereof
0
...
Patent Primary Examiner
‌
Samantha L Shterengarts
0
Patent abstract

The invention features compounds (e.g., macrocyclic compounds) capable of modulating biological processes, for example through binding to a presenter protein (e.g., a member of the FKBP family, a member of the cyclophilin family, or PIN1) and a target protein such as CEP250. These compounds bind endogenous intracellular presenter proteins, such as the FKBPs or cyclophilins, and the resulting binary complexes selectively bind and modulate the activity of the target protein. Formation of a tripartite complex among the presenter protein, the compound, and the target protein is driven by both protein-compound and protein-protein interactions, and both are required for modulation of target protein activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10533016 Compounds that participate in cooperative binding and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us